News

Pharmabiz52m
Plus Therapeutics’ subsidiary, CNSide to launch CNSide cerebrospinal fluid assay platform in US
Plus Therapeutics’ subsidiary, CNSide to launch CNSide cerebrospinal fluid assay platform in US: Houston Saturday, August 2, 2025, 14:00 Hrs [IST] Plus Therapeutics, Inc., a cli ...
Pharmabiz1h
Fresenius Medical Care’s third-party CRO, Frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care
Fresenius Medical Care’s third-party CRO, Frenova announces strategic collaboration advancing genomics-driven, precision kidney disease care: Bad Homburg Saturday, August 2, 202 ...
Pharmabiz2h
Medicenna strengthens IP portfolio with five patents granted for its IL-2 and IL-4 Superkines
US Patent No. 12,202,873 – Superagonists, Partial Agonists and Antagonists of IL-2. Also granted in Switzerland, China, Germany, France, United Kingdom, India, and Japan and allowed in Canada with ...
Pharmabiz3h
US FDA requires major changes to opioid pain medication labelling to emphasize risks
US FDA requires major changes to opioid pain medication labelling to emphasize risks: Maryland Saturday, August 2, 2025, 11:00 Hrs [IST] The US Food and Drug Administration (FDA) ...
Pharmabiz4h
UKHSA study shows RSV vaccine highly effective in preventing hospitalisation
UKHSA study shows RSV vaccine highly effective in preventing hospitalisation: United Kingdom Saturday, August 2, 2025, 10:00 Hrs [IST] A new UK Health Security Agency study - Effe ...
Pharmabiz5h
Mallinckrodt & Endo complete merger to create global, scaled, diversified therapeutics leader
Mallinckrodt & Endo complete merger to create global, scaled, diversified therapeutics leader: Dublin Saturday, August 2, 2025, 09:00 Hrs [IST] Mallinckrodt plc, a leading provide ...
Pharmabiz6h
No impact going forward on the Indian pharma industry due to US tariff policy: IDMA
No impact going forward on the Indian pharma industry due to US tariff policy: IDMA: Shardul Nautiyal, Mumbai Saturday, August 2, 2025, 08:00 Hrs [IST] US President Donald Trumps ...
Pharmabiz6h
AI & biosensing technologies shaping health-tech start-ups to drive innovation in chronic disease prediction
AI & biosensing technologies shaping health-tech start-ups to drive innovation in chronic disease prediction: Nandita Vijayasimha, Bengaluru Saturday, August 2, 2025, 08:00 Hrs [I ...
Pharmabiz6h
Health ministry amends Cosmetics Rules, 2020 to add specifics for cancellation & suspension of licence
Health ministry amends Cosmetics Rules, 2020 to add specifics for cancellation & suspension of licence: Gireesh Babu, New Delhi Saturday, August 2, 2025, 08:00 Hrs [IST] The Union ...
Pharmabiz6h
Karnataka strengthens cleft lip & cleft palate care by training maxillofacial surgeons
Karnataka strengthens cleft lip & cleft palate care by training maxillofacial surgeons: Nandita Vijayasimha, Bengaluru Saturday, August 2, 2025, 08:00 Hrs [IST] Karnataka governme ...
Pharmabiz6h
R Lalvena IAS appointed new director of TN DC department
The Department of Drug Control Administration (DCA) in Tamil Nadu has once again come under the direct leadership of an IAS officer, R Lalvena, following the recent arrest of its former director, P U ...
Pharmabiz20h
Harbour BioMed to present phase II data of HBM4003 & tislelizumab combination in MSS metastatic colorectal cancer at ESMO 2025
Harbour BioMed to present phase II data of HBM4003 & tislelizumab combination in MSS metastatic colorectal cancer at ESMO 2025: Cambridge, Massachusetts Friday, August 1, 2025, 18 ...